TY - JOUR
T1 - Chronic daily headache in adolescents
T2 - An 8-year follow-up study
AU - Wang, Shuu Jiun
AU - Fuh, Jong Ling
AU - Lu, Shiang Ru
N1 - Funding Information:
Dr. Wang has served on the advisory boards of Pfizer, Allergan, and MSD Taiwan; has received speaker honoraria from Taiwan branches of Pfizer, Eli Lilly, Wyeth, Jensen-Cilag, Boehringer Ingelheim, and GSK; and has received research support from the Taiwan National Science Council, Taipei-Veterans General Hospital, and MSD Taiwan. Dr. Fuh serves on a scientific advisory board of Pfizer and has received research support from the Taiwan National Science Council and Taipei-Veterans General Hospital. Dr. Lu has received research support from the Taiwan National Science Council and Kaohsiung Medical University, Taiwan.
PY - 2009/8/11
Y1 - 2009/8/11
N2 - OBJECTIVE: To assess the long-term outcome of a community-based adolescent cohort with chronic daily headache (CDH). METHODS: A field sample of 122 adolescents aged 12-14 years with CDH was established in 2000 (baseline) with short-term follow-up studies in 2001 and 2002. In 2008, the cohort was re-interviewed by physicians via telephone to determine the headache profile for the past year, including Migraine Disability Assessment (MIDAS), a headache disability questionnaire. Presence of CDH was defined as ≥15 headache days/month, average ≥4 hours/day for >3 months. Outcome measures included headache frequency, MIDAS score, and presence of CDH in 2008. RESULTS: A total of 103 subjects (26 male/77 female, mean age 21.6 ± 0.9 years) completed the study (response rate 84.4%). The average monthly headache frequency was 4.7 ± 6.0 (0-30) days. Twenty-eight (27.2%) subjects had moderate or severe headache disability (MIDAS ≥11). Twelve (12%) subjects met CDH criteria, with chronic migraine (n = 10, 83%) as the most common subtype. Two (2%) subjects overused medications. From 2000 to 2008, the frequencies of migraine diagnoses were fairly consistent in this cohort. Presence of migraine at baseline predicted poorer outcome of all 3 measures. Additionally, CDH onset <13 years old, duration ≥2 years, and medication overuse predicted either higher headache frequencies or presence of CDH in 2008. CONCLUSIONS: This long-term follow-up study revealed a marked decline in the frequency of chronic daily headache (CDH). However, one fourth of patients still had significant headache disability. Migraine history was a major factor in evolution of CDH into young adulthood. Early onset and longer duration of CDH implied a protracted disease course.
AB - OBJECTIVE: To assess the long-term outcome of a community-based adolescent cohort with chronic daily headache (CDH). METHODS: A field sample of 122 adolescents aged 12-14 years with CDH was established in 2000 (baseline) with short-term follow-up studies in 2001 and 2002. In 2008, the cohort was re-interviewed by physicians via telephone to determine the headache profile for the past year, including Migraine Disability Assessment (MIDAS), a headache disability questionnaire. Presence of CDH was defined as ≥15 headache days/month, average ≥4 hours/day for >3 months. Outcome measures included headache frequency, MIDAS score, and presence of CDH in 2008. RESULTS: A total of 103 subjects (26 male/77 female, mean age 21.6 ± 0.9 years) completed the study (response rate 84.4%). The average monthly headache frequency was 4.7 ± 6.0 (0-30) days. Twenty-eight (27.2%) subjects had moderate or severe headache disability (MIDAS ≥11). Twelve (12%) subjects met CDH criteria, with chronic migraine (n = 10, 83%) as the most common subtype. Two (2%) subjects overused medications. From 2000 to 2008, the frequencies of migraine diagnoses were fairly consistent in this cohort. Presence of migraine at baseline predicted poorer outcome of all 3 measures. Additionally, CDH onset <13 years old, duration ≥2 years, and medication overuse predicted either higher headache frequencies or presence of CDH in 2008. CONCLUSIONS: This long-term follow-up study revealed a marked decline in the frequency of chronic daily headache (CDH). However, one fourth of patients still had significant headache disability. Migraine history was a major factor in evolution of CDH into young adulthood. Early onset and longer duration of CDH implied a protracted disease course.
UR - http://www.scopus.com/inward/record.url?scp=69449087725&partnerID=8YFLogxK
U2 - 10.1212/WNL.0b013e3181ae2377
DO - 10.1212/WNL.0b013e3181ae2377
M3 - Article
AN - SCOPUS:69449087725
SN - 0028-3878
VL - 73
SP - 416
EP - 422
JO - Neurology
JF - Neurology
IS - 6
ER -